Corneal Flap Transplantation for Macular Hole Repair of High Myopia

Status Active, not recruiting

Clinical Trial Summary

The goal of this clinical trial is to learn about an innovative surgical technique for macular hole repair. This technique is for patients with high myopia using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The main questions it aims to answer are: - Is the innovative surgical technique useful for patients? - Is the surgical technique safe for patients? Participants will: - Undergo PPV combined with corneal flap transplantation to cover the macular hole. - Maintain a prone position for 2 weeks postoperatively. - Be observed by visual acuity, slit lamp, optical coherence tomography (OCT) and fundus photography for 1 year after surgery.

Clinical Trial Description

We describe an innovative surgical technique for macular hole repair using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The corneal flap was sealed with autologous blood. The vitreous cavity was then filled with perfluoropropane (C3F8) or sterile air. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05875909
Study type	Interventional
Source	First People's Hospital of Hangzhou
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 23, 2022
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01121978` - Early Vitrectomy for Macular Tractional Maculopathy	N/A
Completed	`NCT01423149` - Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia	Phase 2
Completed	`NCT01968486` - Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia	Phase 1
Completed	`NCT02806830` - Ocular Discomfort Assessment After Intravitreal Injections	N/A